Gilks CB - Search Results

1

The disparate origins of ovarian cancers: pathogenesis and prevention strategies.

Karnezis AN, Cho KR, Gilks CB, Pearce CL, Huntsman DG. Karnezis AN, et al. Among authors: gilks cb. Nat Rev Cancer. 2017 Jan;17(1):65-74. doi: 10.1038/nrc.2016.113. Epub 2016 Nov 25. Nat Rev Cancer. 2017. PMID: 27885265 Review.

2

Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.

Huntsman DG, Clement PB, Gilks CB, Scully RE. Huntsman DG, et al. Among authors: gilks cb. Am J Surg Pathol. 1994 Apr;18(4):364-75. doi: 10.1097/00000478-199404000-00005. Am J Surg Pathol. 1994. PMID: 7511354 Review.

3

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

Parker RL, Huntsman DG, Lesack DW, Cupples JB, Grant DR, Akbari M, Gilks CB. Parker RL, et al. Among authors: gilks cb. Am J Clin Pathol. 2002 May;117(5):723-8. doi: 10.1309/PEF8-GL6F-YWMC-AG56. Am J Clin Pathol. 2002. PMID: 12090420

4

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.

Hsu FD, Nielsen TO, Alkushi A, Dupuis B, Huntsman D, Liu CL, van de Rijn M, Gilks CB. Hsu FD, et al. Among authors: gilks cb. Mod Pathol. 2002 Dec;15(12):1374-80. doi: 10.1097/01.MP.0000039571.02827.CE. Mod Pathol. 2002. PMID: 12481020

5

Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.

Makretsov N, Gilks CB, Coldman AJ, Hayes M, Huntsman D. Makretsov N, et al. Among authors: gilks cb. Hum Pathol. 2003 Oct;34(10):1001-8. doi: 10.1053/s0046-8177(03)00411-8. Hum Pathol. 2003. PMID: 14608533

6

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.

Nielsen TO, Andrews HN, Cheang M, Kucab JE, Hsu FD, Ragaz J, Gilks CB, Makretsov N, Bajdik CD, Brookes C, Neckers LM, Evdokimova V, Huntsman DG, Dunn SE. Nielsen TO, et al. Among authors: gilks cb. Cancer Res. 2004 Jan 1;64(1):286-91. doi: 10.1158/0008-5472.can-03-1242. Cancer Res. 2004. PMID: 14729636

7

Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.

Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB. Alkushi A, et al. Among authors: gilks cb. Int J Gynecol Pathol. 2004 Apr;23(2):129-37. doi: 10.1097/00004347-200404000-00007. Int J Gynecol Pathol. 2004. PMID: 15084841

8

Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts.

Woo MM, Gilks CB, Verhage HG, Longacre TA, Leung PC, Auersperg N. Woo MM, et al. Among authors: gilks cb. Gynecol Oncol. 2004 May;93(2):315-9. doi: 10.1016/j.ygyno.2004.01.047. Gynecol Oncol. 2004. PMID: 15099939

9

Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data.

Gilks CB. Gilks CB. Int J Gynecol Pathol. 2004 Jul;23(3):200-5. doi: 10.1097/01.pgp.0000130446.84670.93. Int J Gynecol Pathol. 2004. PMID: 15213595 Review.

10

Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression.

Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD. Somasiri A, et al. Among authors: gilks cb. Cancer Res. 2004 Aug 1;64(15):5068-73. doi: 10.1158/0008-5472.CAN-04-0240. Cancer Res. 2004. PMID: 15289306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page